Bill Text: NH SB402 | 2024 | Regular Session | Amended
Bill Title: Relative to allowing pharmacists to administer influenza, COVID-19, and other FDA licensed vaccines without explicit approval from the general court.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Engrossed) 2024-04-24 - Executive Session: 05/01/2024 10:00 am Legislative Office Building 210-211 [SB402 Detail]
Download: New_Hampshire-2024-SB402-Amended.html
SB 402 - AS AMENDED BY THE SENATE
03/07/2024 0825s
2024 SESSION
24-2961
11/05
SENATE BILL 402
SPONSORS: Sen. Birdsell, Dist 19
COMMITTEE: Health and Human Services
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill allows pharmacists to administer influenza, COVID-19, and other FDA licensed vaccines without explicit approval from the general court.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
03/07/2024 0825s 24-2961
11/05
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Pharmacist Administration of Vaccines. Amend the introductory paragraph of RSA 318:16-b to read as follows:
A pharmacist, pharmacy intern, licensed advanced pharmacy technician, or certified pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer influenza and a COVID-19 vaccine, if available, to the general public, [A pharmacist, pharmacy intern, or licensed advanced pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer haemophilus influenza, hepatitis A, hepatitis B, hepatitis A and B, human papillomavirus, meningococcal, pneumococcal, tetanus and diphtheria, varicella, zoster, RSV (respiratory syncytial virus), MMR (measles, mumps, and rubella), and Tdap (tetanus, diphtheria and pertussis) vaccines, which have been approved by the Food and Drug Administration] and vaccines licensed by the United States Food and Drug Administration that are recommended by the United States Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, or successor organization, to individuals 18 years of age or older as ordered by an immunizing pharmacist. The pharmacist, pharmacy intern, licensed advanced pharmacy technician, or certified pharmacy technician shall:
2 Effective Date. This act shall take effect 60 days after its passage.
